Risk-directed treatment intensification significantly reduces the risk of relapse among children and adolescents with acute lymphoblastic leukemia and intrachromosomal amplification of chromosome 21: a comparison of the MRC ALL97/99 and UKALL2003 trials - Moorman, A V; Robinson, H; Schwab, C (J Clin Oncol, 2013)
et al.